10,248 practitioners on the waitlist

Regenerative medicine, built by a clinician — for clinicians.

Next Gen pairs a peer physician education community with a compliant biologics lab — so licensed practitioners can add regenerative tissue-allograft therapies to their practice with the training and supply to back it up.

Johns Hopkins–trained · RCTM co-founder · 6-state licensed · Peer-led & compliance-first
10,248
Practitioners on the waitlist
9+ yrs
Clinical experience
6 states
Licensure — FL · NC · SC · PA · NJ · ID
21 CFR 1271
HCT/P regulatory framework
Community-first

It starts in the community.

Every practitioner comes in through the community — informed first. From there, branch into the path that fits: order for your clinic, or represent to the clinics you know. See the journeys →

One company · two arms

Education and supply, under one credible roof.

Most practitioners hit two walls at once: no compliant training path, and no supplier they trust. Next Gen closes both.

Arm 01 — Community

Next Gen Community

A peer-driven education and training network for physicians entering regenerative medicine — led by a practicing clinician, not a vendor.

  • Founding-member access to the practitioner community
  • Continuing education & clinical training in regenerative protocols
  • Live and virtual workshops led by Dr. Funderlich
  • Protocol library for Wharton's Jelly, chorionic & amniotic allograft integration
Join the Waitlist
Arm 02 — Lab

Next Gen Lab

A practitioner-facing biologics supply built on RCTM production — regulatory transparency and consistent supply as the differentiators.

  • Wharton's Jelly, chorionic & amniotic tissue allografts
  • HCT/P products under 21 CFR Part 1271
  • Practitioner supply agreements & clinic procurement
  • Order tracking & onboarding support included
Order & Supply Access
Leadership

Dr. Marc Funderlich Jr., DC

Medical Director & Co-founder · Next Gen

A practicing chiropractic physician and regenerative-medicine educator who co-built the lab and the community because the industry needed both.

Dr. Funderlich co-founded the Regenerative Cell Therapy Management Corporation (RCTM) — the lab producing Next Gen's Wharton's Jelly and placental tissue-allograft products — and teaches regenerative-medicine and orthobiologic protocols to physicians across the country.

The result is a rare alignment for practitioners: the person setting the standard is the same person supplying the biologics and teaching the clinical protocols.

Dr. Marc Funderlich Jr., DC — Medical Director & Co-founder, Next Gen
JH
Johns HopkinsRegenerative & Stem Cell Technologies (current)
RC
Co-founder, RCTMumbilical & placental tissue-allograft production lab
CE
Regenerative-medicine educatorClinical protocol & orthobiologic training, coast to coast
DC
9+ years clinicalLicensed in FL, NC, SC, PA, NJ & ID
ER
Co-founder, Electro-Regenerative TherapyPEMF regenerative device manufacturer
Next Gen Lab · Biologics

Practitioner-grade biologics, documented and compliant.

Three product families, sourced and processed for licensed clinician use only. Not for direct consumer sale. Formats and pricing are confirmed behind order access.

WHARTON'S JELLY

Wharton's Jelly allograft

Umbilical cord–derived Wharton's Jelly connective-tissue allograft — preservative-free, minimally manipulated, for homologous use, with sourcing and processing documentation.

Formats: 1cc · 2cc  |  HCT/P · 21 CFR 1271
CHORIONIC

Chorionic allograft

Preservative-free chorionic tissue allograft — supplied with the consistency and documentation practitioners need to order with confidence.

Formats: 1cc · 2cc  |  Practitioner-use only
AMNIOTIC

Amniotic membrane allograft

Preservative-free amniotic membrane allograft, developed through RCTM for integration into regenerative clinical protocols.

Formats: 1cc · 2cc  |  Supply agreement required
Get on the list

Join the community or request supply access.

Tell us where you fit and a member of the Next Gen team will follow up. Founding-community and supply-agreement access are practitioner-qualified.

Licensed practitioners & clinicsDC, MD, DO, NP, PA, and clinic owners/directors.
Referred by

For use by licensed medical professionals only — not for direct consumer sale. By submitting you consent to be contacted by the Next Gen team. Biologic products are HCT/P regulated under 21 CFR Part 1271.